UA89397C2 - Средство для профилактики или лечения депрессивных или тревожных расстройств - Google Patents

Средство для профилактики или лечения депрессивных или тревожных расстройств

Info

Publication number
UA89397C2
UA89397C2 UAA200710985A UAA200710985A UA89397C2 UA 89397 C2 UA89397 C2 UA 89397C2 UA A200710985 A UAA200710985 A UA A200710985A UA A200710985 A UAA200710985 A UA A200710985A UA 89397 C2 UA89397 C2 UA 89397C2
Authority
UA
Ukraine
Prior art keywords
remedy
preventive
depression
anxiety neurosis
neurosis
Prior art date
Application number
UAA200710985A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кейсуке Хираи
Масаоми Миямото
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37073564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA89397(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of UA89397C2 publication Critical patent/UA89397C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
UAA200710985A 2005-04-04 2006-04-03 Средство для профилактики или лечения депрессивных или тревожных расстройств UA89397C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005107674 2005-04-04

Publications (1)

Publication Number Publication Date
UA89397C2 true UA89397C2 (ru) 2010-01-25

Family

ID=37073564

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710985A UA89397C2 (ru) 2005-04-04 2006-04-03 Средство для профилактики или лечения депрессивных или тревожных расстройств

Country Status (23)

Country Link
US (1) US20090042861A1 (ru)
EP (1) EP1867641A4 (ru)
JP (1) JP5259181B2 (ru)
KR (1) KR20070118103A (ru)
CN (1) CN101189219A (ru)
AR (1) AR054435A1 (ru)
AU (1) AU2006231752B2 (ru)
BR (1) BRPI0607684A2 (ru)
CA (1) CA2602267A1 (ru)
CL (1) CL2009000980A1 (ru)
CR (1) CR9385A (ru)
GE (1) GEP20105001B (ru)
IL (1) IL186049A0 (ru)
MA (1) MA29677B1 (ru)
MY (1) MY142214A (ru)
NO (1) NO20075599L (ru)
NZ (1) NZ561677A (ru)
PE (1) PE20061355A1 (ru)
RU (1) RU2413510C2 (ru)
TW (1) TWI391132B (ru)
UA (1) UA89397C2 (ru)
WO (1) WO2006107019A1 (ru)
ZA (1) ZA200708445B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248808B1 (en) * 2008-01-31 2014-07-16 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
CA2824430A1 (en) 2011-01-17 2012-07-26 Takeda Pharmaceutical Company Limited Orally dispersible tablet
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP6061924B2 (ja) * 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
RU2571546C1 (ru) * 2014-07-14 2015-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ дифференцированной диагностики и терапии синдрома ночной еды
EP3628316A4 (en) 2017-03-30 2021-04-14 Penello Temporão, José Eduardo MULTI-VITAMIN COMPOSITION TO IMPROVE VERB FLUIDITY AND REDUCE SYMPTOMS OF PERFORMANCE ANXIETY AND ITS PREPARATION PROCESS
CN108451917A (zh) * 2018-03-22 2018-08-28 仁和堂药业有限公司 高稳定性米安色林制剂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
NZ287872A (en) * 1994-06-10 1998-05-27 Smithkline Beecham Plc Cis and trans 3-benzopyranol compounds with a substituted carbonylamino group at position c-4, medicaments
US5780470A (en) * 1995-06-02 1998-07-14 Bristol-Myers Squibb Company Melatonergic indanyl piperazines
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
DK0885210T5 (da) * 1996-03-08 2008-10-13 Takeda Pharmaceutical Tricykliske forbindelser med bindingsaffinitet for melatoninreceptorer, deres fremstilling og anvendelse
JP3509637B2 (ja) * 1998-06-09 2004-03-22 武田薬品工業株式会社 睡眠障害予防治療剤
WO1999063977A2 (en) * 1998-06-09 1999-12-16 Takeda Chemical Industries, Ltd. Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
EE200200717A (et) * 2000-06-27 2004-08-16 Taisho Pharmaceutical Co., Ltd. Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
US6589978B2 (en) * 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
CA2459304A1 (en) * 2001-09-13 2003-03-20 Schering Corporation Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder

Also Published As

Publication number Publication date
BRPI0607684A2 (pt) 2009-09-22
KR20070118103A (ko) 2007-12-13
EP1867641A4 (en) 2010-01-13
JPWO2006107019A1 (ja) 2008-09-25
CA2602267A1 (en) 2006-10-12
RU2413510C2 (ru) 2011-03-10
AU2006231752A1 (en) 2006-10-12
CL2009000980A1 (es) 2009-08-14
EP1867641A1 (en) 2007-12-19
JP5259181B2 (ja) 2013-08-07
TWI391132B (zh) 2013-04-01
GEP20105001B (en) 2010-06-10
MA29677B1 (fr) 2008-08-01
ZA200708445B (en) 2009-03-25
NO20075599L (no) 2007-12-19
TW200719885A (en) 2007-06-01
MY142214A (en) 2010-11-15
US20090042861A1 (en) 2009-02-12
PE20061355A1 (es) 2007-01-15
IL186049A0 (en) 2008-02-09
NZ561677A (en) 2011-02-25
AU2006231752B2 (en) 2012-03-01
WO2006107019A1 (ja) 2006-10-12
AR054435A1 (es) 2007-06-27
CN101189219A (zh) 2008-05-28
CR9385A (es) 2007-12-07
RU2007140986A (ru) 2009-05-20

Similar Documents

Publication Publication Date Title
UA89397C2 (ru) Средство для профилактики или лечения депрессивных или тревожных расстройств
HK1094421A1 (en) (S)-2-n-propylamino-5-hydroxytetralin as a d3-agonist
EA200801959A1 (ru) Высокоразветвленный полипропилен
MX2010002692A (es) Sintesis de catecoles deuterados y derivados de benzo[d][1,3]dioxoles de los mismos.
MX342683B (es) Analogos de ciclopamina.
ZA200604114B (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
KR101434673B9 (ko) 할리콘드린 ｂ 유사체의 제조를 위한 중간체
SG152188A1 (en) Crown for timepiece
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
IL183061A0 (en) Aryloxyethylamine derivatives with a combination of partial dopamine d2 receptor agonism and serotonin reuptake inhibition
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
TW200728310A (en) Process for the preparation of ferri-succinylcasein
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
EP1825856A4 (en) ORAL COMPOSITION CONTAINING DIFRUCTOSE ANHYDRIDE
EP1883626A4 (en) LOW-CALCEMIC 16,23-DIEN-25-OXIMANALOGA OF 1alpha, 25-DIHYDROXY-VITAMIN-D3
MX2007012219A (es) Medida de prevencion o remedio para neurosis paro depresion o ansiedad.
MY147271A (en) Accelerating agent of calcium absorption
WO2010041271A3 (en) Process for preparation of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4-b]furan-8-yl)ethyl] propionamide and novel intermediates thereof
MY148806A (en) Prophylactic or therapeutic agent for nocturnal conduct disorder associated with dementia
EP1931324A4 (en) Α-C, D ANALOGUES OF 1ALPHA, 25-DIHYDROXY-19-NORVITAMIN D3
ZA200902732B (en) Method for the synthesis of n-[3-(2-methoxyphenyl)sulfanyl]-2-methoylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine
TW200800934A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
NO20073390L (no) Fenylpiperaziner med en kombinasjon av affinitet for dopamin-D2-reseptorer og serotoningjenopptaksseter